Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (1081-1090 of 1,104) with videos related to

Pageof 111
Sort By:
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid UsageSung Kwon Kim, Jangsup Moon, Jin Mo Cho, et al.
Blood Cancer Journal|June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantationDong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and MeningiomaSung Kwon Kim, Hong In Yoon, Wan Soo Yoon, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System LymphomaSung Kwon Kim, Ji Eun Park, Kyung Hwan Kim, et al.
Brain Tumor Research and Treatment|April 29, 2021
The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1Jangsup Moon, Min Sung Kim, Young Zoon Kim, et al.
Ejhaem|August 19, 2024
Variation in immunoglobulin use and impact on survival in myelomaKhai Li Chai, Cameron Wellard, Ltp Thao, et al.
Cancer Research and Treatment|May 17, 2018
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer PatientsHyery Kim, Hyoung Jin Kang, Kyung Duk Park, et al.
Brain Tumor Research and Treatment|April 29, 2021
The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1Hong In Yoon, Chan Woo Wee, Young Zoon Kim, et al.
Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
Haematologica|June 6, 2024
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 studyJi Hyun Lee, Jimin Choi, Chang-Ki Min, et al.
Pageof 111

Showing results (1081-1090 of 1,104) with videos related to

Sort By:
Pageof 111
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid UsageSung Kwon Kim, Jangsup Moon, Jin Mo Cho, et al.
Blood Cancer Journal|June 26, 2023
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantationDong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and MeningiomaSung Kwon Kim, Hong In Yoon, Wan Soo Yoon, et al.
Brain Tumor Research and Treatment|May 12, 2020
A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System LymphomaSung Kwon Kim, Ji Eun Park, Kyung Hwan Kim, et al.
Brain Tumor Research and Treatment|April 29, 2021
The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1Jangsup Moon, Min Sung Kim, Young Zoon Kim, et al.
Ejhaem|August 19, 2024
Variation in immunoglobulin use and impact on survival in myelomaKhai Li Chai, Cameron Wellard, Ltp Thao, et al.
Cancer Research and Treatment|May 17, 2018
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer PatientsHyery Kim, Hyoung Jin Kang, Kyung Duk Park, et al.
Brain Tumor Research and Treatment|April 29, 2021
The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1Hong In Yoon, Chan Woo Wee, Young Zoon Kim, et al.
Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
Haematologica|June 6, 2024
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 studyJi Hyun Lee, Jimin Choi, Chang-Ki Min, et al.
Pageof 111